dr. martens plc - DRMTY

DRMTY

Close Chg Chg %
1.72 0.00 0.09%

Closed Market

1.72

0.00 (0.09%)

Volume: 13.89K

Last Updated:

Feb 6, 2026, 12:29 PM EDT

Company Overview: dr. martens plc - DRMTY

DRMTY Key Data

Open

$1.72

Day Range

1.72 - 1.72

52 Week Range

0.78 - 2.60

Market Cap

$884.40M

Shares Outstanding

483.28M

Public Float

N/A

Beta

0.95

Rev. Per Employee

N/A

P/E Ratio

46.57

EPS

N/A

Yield

312.00%

Dividend

$0.04

EX-DIVIDEND DATE

Aug 29, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

3.70K

 

DRMTY Performance

1 Week
 
-8.51%
 
1 Month
 
-12.02%
 
3 Months
 
-29.80%
 
1 Year
 
-15.06%
 
5 Years
 
N/A
 

DRMTY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Dr. Martens Plc - DRMTY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.24B 1.20B 1.10B 1.00B
Sales Growth
+22.93% -2.94% -8.51% -8.80%
Cost of Goods Sold (COGS) incl D&A
500.19M 525.32M 470.00M 444.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
50.13M 65.24M 90.81M 92.74M
Depreciation
43.71M 55.13M 83.53M 84.96M
Amortization of Intangibles
6.42M 10.11M 7.28M 7.78M
COGS Growth
+13.89% +5.02% -10.53% -5.38%
Gross Income
740.45M 678.80M 631.65M 560.02M
Gross Income Growth
+29.90% -8.33% -6.95% -11.34%
Gross Profit Margin
+59.68% +56.37% +57.34% +55.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
422.61M 449.12M 472.89M 482.71M
Research & Development
- - - -
-
Other SG&A
422.61M 449.12M 472.89M 482.71M
SGA Growth
+35.61% +6.27% +5.29% +2.08%
Other Operating Expense
- - - -
-
Unusual Expense
- 273.18K 4.69M 26.28M
EBIT after Unusual Expense
317.57M 224.98M 158.76M 51.03M
Non Operating Income/Expense
(4.37M) (10.59M) (1.51M) 765.40K
Non-Operating Interest Income
- 2.29M 3.77M 4.85M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
20.49M 22.51M 40.44M 40.57M
Interest Expense Growth
-62.28% +9.87% +79.67% +0.30%
Gross Interest Expense
20.49M 22.51M 40.44M 40.57M
Interest Capitalized
- - - -
-
Pretax Income
292.71M 191.88M 116.81M 11.23M
Pretax Income Growth
+216.22% -34.45% -39.12% -90.39%
Pretax Margin
+23.59% +15.94% +10.60% +1.12%
Income Tax
45.21M 36.71M 29.89M 5.49M
Income Tax - Current - Domestic
42.62M 31.78M 20.85M 2.04M
Income Tax - Current - Foreign
5.87M 5.18M 8.04M 4.85M
Income Tax - Deferred - Domestic
(3.28M) (240.75K) 1.00M (1.40M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
247.50M 155.16M 86.92M 5.74M
Minority Interest Expense
- - - -
-
Net Income
247.50M 155.16M 86.92M 5.74M
Net Income Growth
+431.01% -37.31% -43.98% -93.40%
Net Margin Growth
+19.95% +12.89% +7.89% +0.57%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
247.50M 155.16M 86.92M 5.74M
Preferred Dividends
- - - -
-
Net Income Available to Common
247.50M 155.16M 86.92M 5.74M
EPS (Basic)
0.4949 0.3102 0.1767 0.0119
EPS (Basic) Growth
+431.01% -37.32% -43.04% -93.27%
Basic Shares Outstanding
500.05M 500.25M 491.75M 481.15M
EPS (Diluted)
0.4936 0.31 0.1764 0.0118
EPS (Diluted) Growth
+429.61% -37.20% -43.10% -93.31%
Diluted Shares Outstanding
501.45M 500.60M 492.80M 487.05M
EBITDA
367.97M 294.92M 249.57M 170.05M
EBITDA Growth
+21.59% -19.85% -15.38% -31.86%
EBITDA Margin
+29.66% +24.49% +22.65% +16.92%

Dr. Martens Plc in the News